Immunoassay screening remains the cornerstone step in diagnosing AAV. Immunoassay testing for antiproteinase 3 (anti-PR3) and antimyeloperoxidase (anti-MPO) retain an advantage against indirect ...

Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...

Traditionally, cytokines have been measured by radioimmunoassays (RIA) and enzyme-linked immunosorbent assays (ELISA). Unfortunately, these techniques are limited by their detection range and an ...

Novel immunotherapy has revolutionized the landscape of cancer therapy in multiple tumor types since Ipilimumab, the first ICB agent, was approved for the treatment of metastatic melanoma is 2011.

(RTTNews) - Akoya Biosciences, Inc. (AKYA), Thursday announced the launch of a new multiplex immunofluorescence or mIF assay to advance antibody-drug conjugate or ADC development in breast cancer, ...